Our results indicate that women on ART had a lower prevalence of high-risk HPV and a reduction in the incidence of histology diagnosed HSIL-CIN2+ and invasive cervical cancer, after adjustment for CD4 cell count and treatment duration. This evidence concerns the gene CD4 and cervical carcinoma.